We are fortunate to advise world-class, industry-leading companies, helping them tackle novel, complex issues and push the boundaries of technological progress. Our ability and confidence to go to trial is our core strength; our deep bench of experienced trial lawyers represents companies in their most significant matters, helping them protect their intellectual property and launch products. Our lawyers pair extensive experience in the courtroom and the boardroom with a thorough understanding of science and technology.
Paul, Weiss won a significant victory for Edwards Lifesciences in patent litigation brought by Abbott Laboratories concerning Edwards’ PASCAL, an important new medical device recently approved for use in Europe to treat a common form of often-fatal heart disease called mitral regurgitation.
Awards & Recognition
Litigation partner Steve Baughman was named President-Elect of the PTAB Bar Association following the organization’s annual meeting on March 28, 2019.
Paul, Weiss secured a win in the U.S. Court of Appeals for the Federal Circuit for our client, a leading consumer electronics company, against Rosetta Wireless.
Paul, Weiss secured a major appellate victory on behalf of Vanda Pharmaceuticals Inc. before the U.S. Court of Appeals for the Federal Circuit.
Awards & Recognition
Litigation partner Jennifer Wu has been named a New York Law Journal Rising Star for 2018.
Paul, Weiss secured the dismissal of claims against our client Oaktree Capital Management, L.P.
Paul, Weiss won a significant victory for Genentech, Inc. in litigation brought by Baxalta Inc. concerning Genentech’s HEMLIBRA®, a potentially life-changing treatment for hemophilia A.
Paul, Weiss won a major patent victory for Japanese LED maker Nichia Corporation when the Patent Trial and Appeal Board dismissed petitions by U.S. television maker VIZIO seeking a review of the validity of four Nichia patents.
The Patent Trial and Appeal Board (PTAB) is an administrative trial forum established by Congress to provide a faster, more efficient alternative to district court litigation for patent validity challenges.